The obtained TRAIL-functionalized nanovectors (NPTs) improved TRAIL affinity to DR5 and increased its pro-apoptotic potential by nearly 20-fold in human tumor cell lines of different origins, remaining highly selective for TRAIL signaling [36]. This evidence concerns the gene TNFRSF10B and neoplasm.